MiRNA post-transcriptional modification dynamics in T cell activation

T cell activation leads to extensive changes in the miRNA repertoire. Although overall miRNA expression decreases within a few hours of T cell activation, some individual miRNAs are specifically upregulated. Using next-generation sequencing, we assessed miRNA expression and post-transcriptional modi...

Descripción completa

Detalles Bibliográficos
Autores: Rodríguez-Galán, Ana, Dosil, Sara, Gómez, Manuel José, Fernández-Delgado, Irene, Fernández Messina, Lola María, Sánchez-Cabo, Fátima, Sánchez-Madrid, Francisco
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad Complutense de Madrid (UCM)
Repositorio:Docta Complutense
Idioma:inglés
OAI Identifier:oai:docta.ucm.es:20.500.14352/97230
Acceso en línea:https://hdl.handle.net/20.500.14352/97230
Access Level:acceso abierto
Palabra clave:612.017
microRNAs
T cells
Immune activation
RNA modifying enzymes
microRNA post-transcriptonal modification
Biología celular (Biología)
Biología molecular (Biología)
Bioquímica (Biología)
Inmunología
2407 Biología Celular
2403 Bioquímica
2415 Biología Molecular
2412 Inmunología
Descripción
Sumario:T cell activation leads to extensive changes in the miRNA repertoire. Although overall miRNA expression decreases within a few hours of T cell activation, some individual miRNAs are specifically upregulated. Using next-generation sequencing, we assessed miRNA expression and post-transcriptional modification kinetics in human primary CD4+ T cells upon T cell receptor (TCR) or type I interferon stimulation. This analysis identified differential expression of multiple miRNAs not previously linked to T cell activation. Remarkably, upregulated miRNAs showed a higher frequency of 3′ adenylation. TCR stimulation was followed by increased expression of RNA modifying enzymes and the RNA degrading enzymes Dis3L2 and Eri1. In the midst of this adverse environment, 3′ adenylation may serve a protective function that could be exploited to improve miRNA stability for T cell-targeted therapy.